GENETIC PRIVACY-NEUROTECH
Illinois bill restricts genetic and neurotech data collection, requiring explicit consent and establishing privacy protections to prevent unauthorized commercial or governmental use of sensitive biological information.
Illinois bill restricts genetic and neurotech data collection, requiring explicit consent and establishing privacy protections to prevent unauthorized commercial or governmental use of sensitive biological information.
SB 2994 establishes privacy protections for genetic and neurological data in Illinois, restricting how companies and entities can collect, store, and use information derived from DNA analysis and brain-computer interface technologies. The bill creates disclosure requirements and consent mechanisms for individuals whose genetic or neurotech data is gathered, and establishes penalties for unauthorized use or sale of such information.
As genetic testing and neurotechnology become increasingly commercialized, individuals' most sensitive biological information faces potential misuse for discrimination, targeted marketing, or law enforcement purposes without explicit knowledge. This bill addresses a significant regulatory gap by establishing baseline privacy standards in a rapidly advancing technological sector where existing privacy laws lag considerably behind industry capabilities.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.